This company has shut down. Good Therapeutics is no longer operating — its last tracked round was a Series B in 2021.
Explore the Startup GraveyardGood Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
Good Therapeutics has raised $8.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
Good Therapeutics's investors include Digitalis Ventures, RiverVest, Codon Capital, 3×5 Partners, Roche Venture Fund.
Good Therapeutics is headquartered in Seattle, United States.
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
Good Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Good Therapeutics — Funding & Investors." VCBacked, December 30, 2021, https://www.vcbacked.co/company/good-therapeutics. Accessed August 17, 2026.
VCBacked. (2021). Good Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/good-therapeutics
{{cite web |title=Good Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/good-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated